Annual Report

The report describes UCB's 2010 patient-centric biopharmaceutical transformation, with revenue of EUR 3 218 million and 8 898 year-end employees. Its CSR reporting is organized around patients, people, ethics and planet and uses a GRI C+ application level with 15 indicators validated by PricewaterhouseCoopers. Environmental reporting includes 1 015 918 m3 of total water withdrawal, approximately 1 550 million MegaJoules of energy consumption and approximately 15 000 tons of waste, while the safety disclosure reports no fatal injuries.